MedPath
NMPA Approval

Dapagliflozin Tablets

国药准字H20254235

May 20, 2025

Drug Information

达格列净片

片剂

10mg(按C₂₁H₂₅CIO₆ 计)

化学药品

May 20, 2025

Company Information

Applicant Company

山东费县北外环路1号

Manufacturing Company

山东费县北外环路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

达格列净片 - NMPA 批准文号 | MedPath